Zevra Therapeutics, Inc. (ZVRA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$8.73
Day's range
$9.12

Zevra Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 4.46 M $41.53 M   -1.12% 8.06%
WOODLINE PARTNERS LP 05/15/2026 3.45 M $32.16 M   0.00% 6.24%
FMR LLC 05/15/2026 3.21 M $29.93 M   34.19% 5.81%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 2.52 M $23.50 M   42.33% 4.56%
05/15/2026 2.47 M $23.01 M   100.00% 4.46%
CAPTION MANAGEMENT, LLC 05/15/2026 2.00 M $18.67 M   81.87% 3.62%
STATE STREET CORP 05/15/2026 1.56 M $14.55 M   5.30% 2.82%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.37 M $12.79 M   2.25% 2.48%
AIGH CAPITAL MANAGEMENT LLC 04/30/2026 1.20 M $11.18 M   100.00% 2.17%
MORGAN STANLEY 05/15/2026 1.19 M $11.11 M   2.97% 2.16%
LEGAL & GENERAL GROUP PLC 05/08/2026 1.16 M $10.84 M   5.93% 2.10%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 1.16 M $10.78 M   100.00% 2.09%
ROYCE & ASSOCIATES LP 05/12/2026 988.67 K $9.21 M   14.19% 1.79%
683 CAPITAL MANAGEMENT, LLC 05/15/2026 975.00 K $9.09 M   7.73% 1.76%
D. E. SHAW & CO., INC. 05/15/2026 846.46 K $7.89 M   -2.00% 1.53%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 842.32 K $7.85 M   136.45% 1.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 05/15/2026 775.00 K $7.22 M   32.46% 1.40%
GOLDMAN SACHS GROUP INC 05/15/2026 743.12 K $6.93 M   26.23% 1.34%
RETIREMENT PLANNING CO OF NEW ENGLAND, INC. 05/08/2026 651.15 K $6.07 M   -1.78% 1.18%
CITADEL ADVISORS LLC 05/15/2026 626.70 K $5.84 M   -25.65% 1.13%
MILLENNIUM MANAGEMENT LLC 05/15/2026 590.27 K $5.50 M   -47.96% 1.07%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 554.80 K $5.17 M   259.17% 1.00%
SCHRODER INVESTMENT MANAGEMENT GROUP 05/14/2026 506.03 K $4.44 M   0.00% 0.91%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2026 480.00 K $4.47 M   -15.65% 0.87%
05/08/2026 466.30 K $4.35 M   100.00% 0.84%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 452.80 K $4.22 M   129.61% 0.82%
TUDOR INVESTMENT CORP ET AL 05/15/2026 443.11 K $4.13 M   -35.98% 0.80%
MARSHALL WACE, LLP 05/15/2026 439.95 K $4.10 M   -34.31% 0.80%
NORTHERN TRUST CORP 05/14/2026 436.95 K $4.07 M   4.50% 0.79%
UBS GROUP AG 05/05/2026 422.05 K $3.93 M   47.83% 0.76%
STRATOS WEALTH PARTNERS, LTD. 04/28/2026 408.00 K $3.80 M   -0.24% 0.74%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 395.88 K $3.69 M   100.00% 0.72%
JPMORGAN CHASE & CO 05/13/2026 378.93 K $3.33 M   -8.08% 0.69%
MYSTIC ASSET MANAGEMENT, INC. 05/08/2026 361.28 K $3.37 M   4.26% 0.65%
FLPUTNAM INVESTMENT MANAGEMENT CO 05/05/2026 350.50 K $3.27 M   100.00% 0.63%
PROPEL BIO MANAGEMENT, LLC 05/14/2026 282.42 K $2.64 M   343.47% 0.51%
CAPTION MANAGEMENT, LLC 05/15/2026 255.24 K $2.38 M   -52.74% 0.46%
CITADEL ADVISORS LLC 05/15/2026 243.40 K $2.27 M   54.83% 0.44%
JANNEY MONTGOMERY SCOTT LLC 04/22/2026 236.83 K $2.21 M   16.73% 0.43%
JANE STREET GROUP, LLC 05/12/2026 221.06 K $2.06 M   -60.80% 0.40%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 200.00 K $1.86 M   -27.27% 0.36%
NUVEEN, LLC 04/30/2026 192.59 K $1.79 M   34.55% 0.35%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 186.58 K $1.74 M   -36.34% 0.34%
SQUAREPOINT OPS LLC 05/15/2026 182.86 K $1.70 M   -42.33% 0.33%
JANE STREET GROUP, LLC 05/12/2026 178.70 K $1.67 M   274.63% 0.32%
HENNION & WALSH ASSET MANAGEMENT, INC. 05/13/2026 177.16 K $1.65 M   26.92% 0.32%
KOVACK ADVISORS, INC. 05/13/2026 175.23 K $1.65 M   -0.06% 0.32%
BANK OF NEW YORK MELLON CORP 05/05/2026 172.43 K $1.61 M   -0.99% 0.31%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 161.98 K $1.51 M   -10.32% 0.29%
PHOCAS FINANCIAL CORP. 05/01/2026 159.42 K $1.49 M   100.00% 0.29%

Zevra Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 180 institutional investors and hedge funds held shares of Zevra Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 4.46 M

Woodline Partners LP: 3.45 M

FMR LLC: 3.21 M

Nantahala Capital Management, LLC: 2.52 M

STATE STREET CORP: 1.56 M

GEODE CAPITAL MANAGEMENT, LLC: 1.37 M

74.70% of Zevra Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 44.58 M shares in the last 24 months. This purchase volume represents approximately $406.60 M in transactions.